Vietnam medical experts discuss RSV prevention for infants

Medical experts and the Vietnam Pediatric Association recently held a seminar to discuss prevention methods for Respiratory Syncytial Virus (RSV) in infants. The event was supported by Sanofi-Aventis Vietnam.

RSV is a major global health concern, accounting for over 60% of acute respiratory infections in infants and young children. It is highly contagious, with statistics suggesting that 9 out of 10 children contract the virus within their first two years of life. Globally, RSV is a leading cause of hospitalization for children under one year old.

Professor Tran Minh Dien, Director of the National Children's Hospital and President of the Vietnam Pediatric Association, noted that RSV is a primary cause of severe lower respiratory tract infections, such as pneumonia and bronchiolitis. He highlighted the concern that many children requiring ICU admission or mechanical ventilation are previously healthy, full-term infants.

Infants are particularly vulnerable due to underdeveloped immune systems and narrower airways, which are easily obstructed by mucus. Severe RSV infections in the first year of life can lead to long-term complications, including recurrent wheezing, asthma, and reduced lung function. As there is currently no specific treatment for the virus, experts are focusing on preventative measures, including vaccination for pregnant women.